Wiley Bros. Aintree Capital, LLC United Therapeutics Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,807 shares of UTHR stock, worth $804,892. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,807
Previous 1,775
1.8%
Holding current value
$804,892
Previous $547,000
5.12%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
751Shares Held
43.4MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.98 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1.06 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$965 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$944 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $20.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...